Healthcare upgrades and initiations for Friday

AstraZeneca (AZN +0.5%) upgraded to Buy at Liberum.

Ligand Pharmaceuticals (LGND +4.4%) upgraded to Hold from Sell at Cantor.

Vivus (VVUS +3.6%) initiated at Hold at WallachBeth.

Synageva BioPharma (GEVA +5.9%) initiated at Buy at Goldman. Price target is $72 (upside of 37% from Thursday's close).

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs